ADXN Addex Therapeutics Ltd

NASDAQ
$3.65

Addex Therapeutics Ltd (ADXN) Institutional Ownership

What the institutions did with ADXN last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers compared
5
filed both this quarter and last
Managers holding
2
-2 on the quarter
Buyers
1
1 opened new
Sellers
3
3 sold out entirely
Buyer share
25.0%
of managers who traded it
Breadth
-50.0
net buyers, as a share of those trading

Only 5 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
UBS Group AG 47 97.9%
SBI Securities Co., Ltd. 1 2.1%

Largest changes

Manager Action Previous Current Change
MORGAN STANLEY Sold Out 301 0 -301
GAMMA Investing LLC Sold Out 81 0 -81
RHUMBLINE ADVISERS Sold Out 72 0 -72
UBS Group AG New 0 47 +47

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.